Resveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathway.
about
Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells.Knockdown of survivin results in inhibition of epithelial to mesenchymal transition in retinal pigment epithelial cells by attenuating the TGFβ pathway.TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression.
P2860
Resveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resveratrol inhibits transform ...... suppressing the Smad pathway.
@en
Resveratrol inhibits transform ...... suppressing the Smad pathway.
@nl
type
label
Resveratrol inhibits transform ...... suppressing the Smad pathway.
@en
Resveratrol inhibits transform ...... suppressing the Smad pathway.
@nl
prefLabel
Resveratrol inhibits transform ...... suppressing the Smad pathway.
@en
Resveratrol inhibits transform ...... suppressing the Smad pathway.
@nl
P2093
P2860
P356
P1476
Resveratrol inhibits transform ...... suppressing the Smad pathway.
@en
P2093
Chang-Min Liang
Ching-Long Chen
Jiann-Torng Chen
Ming-Cheng Tai
Yi-Hao Chen
P2860
P304
P356
10.2147/DDDT.S126743
P407
P577
2017-01-11T00:00:00Z